These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 38649404)

  • 1. An increase in ER stress and unfolded protein response in iPSCs-derived neuronal cells from neuronopathic Gaucher disease patients.
    Pornsukjantra T; Saikachain N; Sutjarit N; Khongkrapan A; Tubsuwan A; Bhukhai K; Tim-Aroon T; Anurathapan U; Hongeng S; Asavapanumas N
    Sci Rep; 2024 Apr; 14(1):9177. PubMed ID: 38649404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated glucosylsphingosine in Gaucher disease induced pluripotent stem cell neurons deregulates lysosomal compartment through mammalian target of rapamycin complex 1.
    Srikanth MP; Jones JW; Kane M; Awad O; Park TS; Zambidis ET; Feldman RA
    Stem Cells Transl Med; 2021 Jul; 10(7):1081-1094. PubMed ID: 33656802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. UPR activation and CHOP mediated induction of GBA1 transcription in Gaucher disease.
    Braunstein H; Maor G; Chicco G; Filocamo M; Zimran A; Horowitz M
    Blood Cells Mol Dis; 2018 Feb; 68():21-29. PubMed ID: 27856178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. No evidence for activation of the unfolded protein response in neuronopathic models of Gaucher disease.
    Farfel-Becker T; Vitner E; Dekel H; Leshem N; Enquist IB; Karlsson S; Futerman AH
    Hum Mol Genet; 2009 Apr; 18(8):1482-8. PubMed ID: 19193629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated Dkk1 Mediates Downregulation of the Canonical Wnt Pathway and Lysosomal Loss in an iPSC Model of Neuronopathic Gaucher Disease.
    Srikanth MP; Feldman RA
    Biomolecules; 2020 Dec; 10(12):. PubMed ID: 33287247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lysosomal functions and dysfunctions: Molecular and cellular mechanisms underlying Gaucher disease and its association with Parkinson disease.
    Horowitz M; Braunstein H; Zimran A; Revel-Vilk S; Goker-Alpan O
    Adv Drug Deliv Rev; 2022 Aug; 187():114402. PubMed ID: 35764179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CRISPR/Cas9 Editing for Gaucher Disease Modelling.
    Pavan E; Ormazabal M; Peruzzo P; Vaena E; Rozenfeld P; Dardis A
    Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32380730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuronal accumulation of glucosylceramide in a mouse model of neuronopathic Gaucher disease leads to neurodegeneration.
    Farfel-Becker T; Vitner EB; Kelly SL; Bame JR; Duan J; Shinder V; Merrill AH; Dobrenis K; Futerman AH
    Hum Mol Genet; 2014 Feb; 23(4):843-54. PubMed ID: 24064337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A New Glucocerebrosidase Chaperone Reduces α-Synuclein and Glycolipid Levels in iPSC-Derived Dopaminergic Neurons from Patients with Gaucher Disease and Parkinsonism.
    Aflaki E; Borger DK; Moaven N; Stubblefield BK; Rogers SA; Patnaik S; Schoenen FJ; Westbroek W; Zheng W; Sullivan P; Fujiwara H; Sidhu R; Khaliq ZM; Lopez GJ; Goldstein DS; Ory DS; Marugan J; Sidransky E
    J Neurosci; 2016 Jul; 36(28):7441-52. PubMed ID: 27413154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered Differentiation Potential of Gaucher's Disease iPSC Neuronal Progenitors due to Wnt/β-Catenin Downregulation.
    Awad O; Panicker LM; Deranieh RM; Srikanth MP; Brown RA; Voit A; Peesay T; Park TS; Zambidis ET; Feldman RA
    Stem Cell Reports; 2017 Dec; 9(6):1853-1867. PubMed ID: 29198828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic delivery of recombinant glucocerebrosidase enzyme-containing extracellular vesicles to human cells from Gaucher disease patients.
    Janpipatkul K; Sutjarit N; Tangprasittipap A; Chaiamarit T; Innachai P; Suksen K; Chokpanuwat T; Tim-Aroon T; Anurathapan U; Jearawiriyapaisarn N; Tubsuwan A; Bowornpinyo S; Asavapanumas N; Chairoungdua A; Bhukhai K; Hongeng S
    Orphanet J Rare Dis; 2024 Oct; 19(1):363. PubMed ID: 39358794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unfolded protein response in Gaucher disease: from human to Drosophila.
    Maor G; Rencus-Lazar S; Filocamo M; Steller H; Segal D; Horowitz M
    Orphanet J Rare Dis; 2013 Sep; 8():140. PubMed ID: 24020503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered TFEB-mediated lysosomal biogenesis in Gaucher disease iPSC-derived neuronal cells.
    Awad O; Sarkar C; Panicker LM; Miller D; Zeng X; Sgambato JA; Lipinski MM; Feldman RA
    Hum Mol Genet; 2015 Oct; 24(20):5775-88. PubMed ID: 26220978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship between glucocerebrosidase mutations and Parkinson disease.
    Migdalska-Richards A; Schapira AH
    J Neurochem; 2016 Oct; 139 Suppl 1(Suppl Suppl 1):77-90. PubMed ID: 26860875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple pathogenic proteins implicated in neuronopathic Gaucher disease mice.
    Xu YH; Xu K; Sun Y; Liou B; Quinn B; Li RH; Xue L; Zhang W; Setchell KD; Witte D; Grabowski GA
    Hum Mol Genet; 2014 Aug; 23(15):3943-57. PubMed ID: 24599400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Animal Models for the Study of Gaucher Disease.
    Cabasso O; Kuppuramalingam A; Lelieveld L; Van der Lienden M; Boot R; Aerts JM; Horowitz M
    Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuronopathic Gaucher disease: Beyond lysosomal dysfunction.
    Arévalo NB; Lamaizon CM; Cavieres VA; Burgos PV; Álvarez AR; Yañez MJ; Zanlungo S
    Front Mol Neurosci; 2022; 15():934820. PubMed ID: 35992201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Properties of neurons derived from induced pluripotent stem cells of Gaucher disease type 2 patient fibroblasts: potential role in neuropathology.
    Sun Y; Florer J; Mayhew CN; Jia Z; Zhao Z; Xu K; Ran H; Liou B; Zhang W; Setchell KD; Gu J; Grabowski GA
    PLoS One; 2015; 10(3):e0118771. PubMed ID: 25822147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induced pluripotent stem cell line (INSAi001-A) from a Gaucher disease type 3 patient compound heterozygote for mutations in the GBA1 gene.
    Duarte AJ; Ribeiro D; Santos R; Moreira L; Bragança J; Amaral O
    Stem Cell Res; 2019 Dec; 41():101595. PubMed ID: 31678773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous infusion of iPSC-derived neural precursor cells increases acid β-glucosidase function in the brain and lessens the neuronopathic phenotype in a mouse model of Gaucher disease.
    Peng Y; Liou B; Inskeep V; Blackwood R; Mayhew CN; Grabowski GA; Sun Y
    Hum Mol Genet; 2019 Oct; 28(20):3406-3421. PubMed ID: 31373366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.